Navigating the Grey Zone for Antenatal Corticosteroids

University of British Columbia

Status: Unknown

Conditions: Decision Making, Shared; Preterm Birth; Pregnancy

Treatments: Behavioral: Decision support tool

Study type: Interventional

Funder types: Other

Identifiers

NCT04792112

H20-03071

Details and patient eligibility

About

The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.

Enrollment: 460 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 year or older.
• Delivered a live neonate at 34+0 to 36+6 weeks of gestation.
• Speaks English.
• Agrees to participate in the questionnaire during their first week post-partum.
• Delivered at one of the six participating obstetrical hospitals.

Exclusion criteria

• None.

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

460 participants in 2 patient groups

Guideline + decision support tool

Experimental group

Description:

A decision support tool summarizing harms and benefits of late preterm antenatal corticosteroids will be integrated into the clinical practice guideline available to clinicians in the hospitals in the experimental arm.

Treatment:

Behavioral: Decision support tool

Guideline only

No Intervention group

Description:

Clinicians in the hospitals in the 'no-intervention' arm will have access to the standard guideline only (without the integrated decision support tool).